<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03876860</url>
  </required_header>
  <id_info>
    <org_study_id>211334</org_study_id>
    <nct_id>NCT03876860</nct_id>
  </id_info>
  <brief_title>An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis</brief_title>
  <official_title>An Enhanced Vaginal Dilator Model to Improve Patient Adherence and Reduce Radiation-Induced Vaginal Stenosis: a Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Margaret Liotta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loyola University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized control trial aimed to decreased radiation-induced vaginal stenosis in
      patients with endometrial or cervical cancer treated with post-operative external beam
      radiation therapy with or without brachytherapy. The intervention is an enhanced vaginal
      dilator model, including a silicone band placed at the desired depth of dilator insertion.
      The new model will be compared against the traditional vaginal dilator model used as our
      institutional standard of care. We hypothesize the enhanced model will improve adherence,
      correct use and efficacy of vaginal dilator use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pelvic radiotherapy and vaginal brachytherapy play an integral role in managing gynecological
      malignancies, including endometrial and cervical cancer. Radiation-induced vaginal stenosis
      is a well recognized complication of radiation therapy and can result in painful, inadequate
      pelvic exams and sexual dysfunction. Current recommendations to prevent and manage vaginal
      stenosis include regular use of vaginal dilators, with our institutional recommendation being
      three times weekly for 10 minutes. Compliance varies among studies but is generally perceived
      to be low. Limited literature exists regarding ways to improve adherence and correct use of
      vaginal dilators. The goal of this study is to enhance the standard vaginal dilator model to
      improve patient outcomes. Eligibility includes women with endometrial or cervical cancer
      treated with post-operative external beam radiation therapy with or without brachytherapy.
      Patients will be randomized to either the standard vaginal dilator or an enhanced model. The
      enhanced dilator model includes the addition of a silicone band placed at the desired depth
      of vaginal dilator insertion, aimed to aide in correct insertion length. The primary aim of
      the study is patient adherence to vaginal dilator use. Secondary aims include vaginal length,
      CTCAE v5.0 grading scale for vaginal stricture, sexual function, self-reported comfort with
      use, and discomfort during office pelvic exams. Outcomes will be obtained based on physician
      reporting and patient surveys. All analyses will be completed by a biostatistician in the
      Clinical Research Office using SAS version 9.4.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 24, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized control trial with two arms including control arm and experimental arm</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participant Adherence</measure>
    <time_frame>12 months</time_frame>
    <description>Number of participants who use the vaginal dilator at least three times per week</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vaginal Length</measure>
    <time_frame>12 months</time_frame>
    <description>Vaginal length (in centimeters) measured using a POP-Q wooden stick</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal stenosis grading scale</measure>
    <time_frame>12 months</time_frame>
    <description>The vaginal stenosis grading scale is an ordinal scale ranging from 0 (no vaginal stenosis) to 3 (severe vaginal stenosis) as defined by the Common Terminology Criteria for Adverse Events Version 5.0 - vaginal stricture.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in female sexual function</measure>
    <time_frame>12 months</time_frame>
    <description>The female sexual function index (FSFI) is a measure of sexual functioning in women. Scores range from 2 to 36 with higher scores indicating greater functioning. The baseline FSFI score is subtracted from the 12-month follow-up FSFI score for each participant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort with pelvic exams</measure>
    <time_frame>12 months</time_frame>
    <description>Discomfort with pelvic exams is measured using a visual analog scale (VAS) ranging from 0 (no discomfort) to 10 (severe discomfort)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort with dilator use</measure>
    <time_frame>12 months</time_frame>
    <description>Discomfort with use of the dilator is measured using a visual analog scale (VAS) ranging from 0 (no discomfort) to 10 (severe discomfort)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">118</enrollment>
  <condition>Endometrial Cancer</condition>
  <condition>Cervical Cancer</condition>
  <condition>Vaginal Stricture</condition>
  <condition>Radiation Toxicity</condition>
  <arm_group>
    <arm_group_label>Standard Dilator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in control arm (active comparator) will receive standard vaginal dilator with standard set of instructions for dilator use, including both verbal and written instructions. Recommended dilator use is three-times weekly for ten minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Silicone Dilator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in experimental arm will receive standard vaginal dilator with addition of silicone ring with standard set of instructions for dilator use, including both verbal and written instructions. Recommended dilator use is three-times weekly for ten minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Silicone Dilator</intervention_name>
    <description>Addition of silicone band to standard vaginal dilator</description>
    <arm_group_label>Silicone Dilator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Dilator</intervention_name>
    <description>Standard vaginal dilator</description>
    <arm_group_label>Standard Dilator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of endometrial or cervical cancer

          -  Undergoing external beam radiation therapy with or without brachytherapy

          -  English-speaking

        Exclusion Criteria:

          -  History or current presence of fistula
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margaret R Liotta, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loyola University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Danielle M Krause, MD</last_name>
    <phone>7082164033</phone>
    <email>dkrause@lumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margaret R Liotta, DO</last_name>
    <phone>7083272104</phone>
    <email>mliotta@lumc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Krause, MD</last_name>
      <phone>708-216-4033</phone>
      <email>dkrause@lumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Margaret Liotta, DO</last_name>
      <phone>7083272104</phone>
      <email>mliotta@lumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Margaret Liotta, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006 Jan-Feb;16(1):288-93.</citation>
    <PMID>16445647</PMID>
  </reference>
  <reference>
    <citation>Brand AH, Do V, Stenlake A. Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy? Int J Gynecol Cancer. 2012 Jun;22(5):897-904. doi: 10.1097/IGC.0b013e31824d7243.</citation>
    <PMID>22552831</PMID>
  </reference>
  <reference>
    <citation>Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):825-30.</citation>
    <PMID>8244811</PMID>
  </reference>
  <reference>
    <citation>Hanlon A, Small W Jr, Strauss J, Lin LL, Hanisch L, Huang L, Bai J, Wells J, Bruner DW. Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study. Cancer Nurs. 2018 May/Jun;41(3):200-209. doi: 10.1097/NCC.0000000000000500.</citation>
    <PMID>28437283</PMID>
  </reference>
  <reference>
    <citation>Harkenrider MM, Block AM, Alektiar KM, Gaffney DK, Jones E, Klopp A, Viswanathan AN, Small W Jr. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review. Brachytherapy. 2017 Jan - Feb;16(1):95-108. doi: 10.1016/j.brachy.2016.04.005. Epub 2016 May 31. Review.</citation>
    <PMID>27260082</PMID>
  </reference>
  <reference>
    <citation>Jeffries SA, Robinson JW, Craighead PS, Keats MR. An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):404-11. Epub 2006 Mar 20.</citation>
    <PMID>16542794</PMID>
  </reference>
  <reference>
    <citation>Kirchheiner K, Nout RA, Lindegaard JC, Haie-Meder C, Mahantshetty U, Segedin B, Jürgenliemk-Schulz IM, Hoskin PJ, Rai B, Dörr W, Kirisits C, Bentzen SM, Pötter R, Tanderup K; EMBRACE Collaborative Group. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol. 2016 Jan;118(1):160-6. doi: 10.1016/j.radonc.2015.12.025. Epub 2016 Jan 9.</citation>
    <PMID>26780997</PMID>
  </reference>
  <reference>
    <citation>Kirchheiner K, Fidarova E, Nout RA, Schmid MP, Sturdza A, Wiebe E, Kranz A, Polterauer S, Pötter R, Dörr W. Radiation-induced morphological changes in the vagina. Strahlenther Onkol. 2012 Nov;188(11):1010-7. doi: 10.1007/s00066-012-0222-0. Epub 2012 Sep 29.</citation>
    <PMID>23053157</PMID>
  </reference>
  <reference>
    <citation>Law E, Kelvin JF, Thom B, Riedel E, Tom A, Carter J, Alektiar KM, Goodman KA. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol. 2015 Jul;116(1):149-55. doi: 10.1016/j.radonc.2015.06.018. Epub 2015 Jul 8.</citation>
    <PMID>26164775</PMID>
  </reference>
  <reference>
    <citation>Miles T, Johnson N. Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev. 2014 Sep 8;(9):CD007291. doi: 10.1002/14651858.CD007291.pub3. Review.</citation>
    <PMID>25198150</PMID>
  </reference>
  <reference>
    <citation>Morris L, Do V, Chard J, Brand AH. Radiation-induced vaginal stenosis: current perspectives. Int J Womens Health. 2017 May 2;9:273-279. doi: 10.2147/IJWH.S106796. eCollection 2017. Review.</citation>
    <PMID>28496367</PMID>
  </reference>
  <reference>
    <citation>Park HS, Ratner ES, Lucarelli L, Polizzi S, Higgins SA, Damast S. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma. Brachytherapy. 2015 Jul-Aug;14(4):464-70. doi: 10.1016/j.brachy.2015.03.001. Epub 2015 Apr 14.</citation>
    <PMID>25887343</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 27, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Loyola University</investigator_affiliation>
    <investigator_full_name>Margaret Liotta</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Vaginal dilator</keyword>
  <keyword>Vaginal stenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make individual participant data available to other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

